17 alpha-hydroxyprogesterone caproate has been researched along with Hormone-Dependent Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chepick, OF | 1 |
Charkviani, TL | 1 |
Loutfi, G; Vishnevsky, AS | 1 |
Fujimoto, J; Fujita, H; Nakata, Y; Okada, H | 1 |
2 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Morphological aspects of the hormone-induced pathomorphosis of endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Adult; Antineoplastic Agents; Cell Division; Chemotherapy, Adjuvant; Clomiphene; Contraceptives, Oral, Hormonal; Endometrial Neoplasms; Enzymes; Estradiol; Female; Glycogen; Humans; Hydroxyprogesterones; Microscopy, Electron; Neoplasm Staging; Neoplasms, Hormone-Dependent; Remission Induction | 1993 |
Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Survival Rate; Tamoxifen | 1993 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Optimal variants of treatment of stage I endometrial carcinoma and its choice.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Retrospective Studies; Survival Rate; Treatment Outcome | 1993 |
[Hormone dependency and progestogen therapy in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Cell Division; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Norethindrone; Tamoxifen; Tumor Stem Cell Assay; Uterine Neoplasms | 1987 |